Ketamine Nasal Spray Approved as Standalone Treatment for Tough Depression Cases
An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other options.
Respondents who said they used other drugs recreationally were also likelier to say they used ketamine during the past year ...
A multidisciplinary approach, including ketamine withdrawal and symptom management, is essential to mitigate long-term ...
"Treatment-resistant depression can be very complicated, especially for patients who do not respond to oral antidepressants ...
Musk himself has said he uses the drug to treat depression, and he's frequently posted about it on X generally over the years ...
US Weekly on MSN6d
What Celebrities and Doctors Have Said About Ketamine Use: Chrissy Teigen, Matthew Perry, MoreCelebrities like Chrissy Teigen and Matthew Perry have been open about using ketamine for their mental health – here's what ...
A now-former Iowa paramedic is facing charges after allegedly giving a man in need the wrong medication — and then failing to ...
They've found recreational use has grown dramatically over the past decade. It increased more than 80 percent from 2015 to ...
Also in the news, "renal denervation" shows promise as a treatment for high blood pressure; an estimated 17 million U.S. adults struggle with long-covid with no new treatments in sight; inequality ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback